Arvix products are developed within a comprehensive quality framework designed to meet regulatory requirements and support hospital compliance processes.
Arvix Biologics products are regulated as Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) under 21 CFR Part 1271. Our products meet the criteria outlined in 21 CFR 1271.10(a) for regulation solely under Section 361 of the Public Health Service Act.
Arvix Biologics products are regulated as Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) under 21 CFR Part 1271. Our products meet the criteria outlined in 21 CFR 1271.10(a) for regulation solely under Section 361 of the Public Health Service Act.
This regulatory pathway requires compliance with donor eligibility determination, current good tissue practice, establishment registration, and product listing requirements. Arvix maintains systems designed to address these regulatory obligations.
Processing methods designed to preserve tissue structure and characteristics
Intended for wound coverage applications consistent with amnion membrane function
Products applied topically without systemic metabolic activity dependence

Comprehensive donor screening, testing, and processing controls designed to reduce contamination risk and ensure product safety.
Comprehensive medical and social history review conducted by qualified personnel. Screening criteria designed to identify risk factors for relevant communicable diseases.
Required infectious disease testing performed using FDA-licensed, approved, or cleared donor screening tests. Testing conducted by laboratories certified under CLIA.
Controlled environment processing with documented procedures, environmental monitoring, and personnel training. Aseptic technique and contamination prevention protocols.
Comprehensive tracking system maintaining donor-to-distribution records. Documentation designed to support adverse event investigation and product recall capabilities if needed.
Complete donor eligibility determination documentation including screening, testing, and assessment records maintained per regulatory requirements.
Batch records documenting all processing steps, environmental conditions, personnel, and quality control testing for each production lot.
Records linking specific product lots to distribution locations, enabling rapid identification and communication in the event of safety concerns.
Product labeling designed to meet regulatory requirements and support hospital inventory management and tracking systems.
Comprehensive quality framework encompassing all aspects of tissue recovery, processing, storage, and distribution.
Documented procedures for all critical processes with version control and training requirements.
Training programs and competency assessment for all personnel involved in tissue handling.
Release testing protocols including sterility, bioburden, and tissue integrity assessments.
Systems for receiving, investigating, and reporting adverse reactions and product deviations.
Our VAC packet includes comprehensive regulatory positioning, quality system overview, and compliance documentation designed to support hospital review processes.